Editorial
|
Gene therapy for radiation protection
|
1495
|
JS Greenberger
|
Full Article PDF
|
 |
|
Perspective
|
Considerations and challenges for the achievement of targeted gene delivery
|
1497
|
DT Curiel MD
|
Full Article PDF
|
 |
|
Review
|
Gene therapy in transplantation
|
1499
|
N Giannoukakis, AW Thomson & PD Robbins
|
Abstract Full Article PDF
|
 |
|
Papers
|
Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells
|
1512
|
D McDonald, L Stockwin, T Matzow, ME Blair Zajdel & GE Blair
|
Abstract Full Article PDF
|
 |
Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
|
1520
|
H Fechner, A Haack, H Wang, X Wang, K Eizema, M Pauschinger, RG Schoemaker, R van Veghel, AB Houtsmuller, H-P Schultheiss, JMJ Lamers & W Poller
|
Abstract Full Article PDF
|
 |
Efficient infection of mature skeletal muscle with herpes simplex virus vectors by using dextran sulfate as a co-receptor
|
1536
|
SN Yeung, K Bockhold & F Tufaro
|
Abstract Full Article PDF
|
 |
Infection of intact human islets by a lentiviral vector
|
1545
|
N Giannoukakis, Z Mi, A Gambotto, A Eramo, C Ricordi, M Trucco & PD Robbins
|
Abstract Full Article PDF
|
 |
Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors
|
1552
|
K-W Peng, RG Vile, F-L Cosset & SJ Russell
|
Abstract Full Article PDF
|
 |
Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres
|
1558
|
CB Matthews, G Jenkins, JM Hilfinger & BL Davidson
|
Abstract Full Article PDF
|
 |
Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
|
1565
|
RJ Parks, CM Evelegh & FL Graham
|
Abstract Full Article PDF
|
 |
Immune responses to adenovirus and adeno-associated virus in humans
|
1574
|
N Chirmule, KJ Propert, SA Magosin, Y Qian, R Qian & JM Wilson
|
Abstract Full Article PDF
|
 |
Gene therapy expression vectors based on the clotting Factor IX promoter
|
1584
|
H Hoag, J Gore, D Barry & CR Mueller
|
Abstract Full Article PDF
|
 |
HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect
|
1590
|
X-J Yao, GP Kobinger, S Dandache, N Rougeau & EA Cohen
|
Abstract Full Article PDF
|
 |
Use of protamine to augment adenovirus-mediated cancer gene therapy
|
1600
|
M Lanuti, C El Kouri, SD Force, MY Chang, K Amin, K Xu, IA Blair, LR Kaiser & SM Albelda
|
Abstract Full Article PDF
|
 |
Bone marrow stromal cells as a vehicle for gene transfer
|
1611
|
L Ding, S Lu, RB Batchu, RL Saylors III & NC Munshi
|
Abstract Full Article PDF
|
 |
Endothelial cell DNA transfer and expression using Petri dish electroporation and the nonreplicating vaccinia virus/T7 RNA polymerase hybrid system
|
1617
|
EW Lewis, TJ Rudo, MA Rahman St John, JL Chu, AW Heinze, BH Howard & KA Engleka
|
Abstract Full Article PDF
|
 |
Antitumor effect and cellular immunity activation by murine interferon- gene transfer against intracerebral glioma in mouse
|
1626
|
A Natsume, M Mizuno, Y Ryuke & J Yoshida
|
Abstract Full Article PDF
|
 |
|
Brief Communications
|
Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine
|
1634
|
P Marschall, N Malik & Z Larin
|
Abstract Full Article PDF
|
 |
The equine herpes virus 4 thymidine kinase is a better suicide gene than the human herpes virus 1 thymidine kinase
|
1638
|
L Loubière, M Tiraby, C Cazaux, E Brisson, M Grisoni, JC Zhao-Emonet, G Tiraby & D Klatzmann
|
Abstract Full Article PDF
|
 |
 |
 |